In various types of cancer, including melanoma, MDSCs were shown to induce tumor growth and progression by promoting the immunosuppressive TME, e.g., by inhibiting NK cells, CD4+ T cells and CD8+ T cells, and stimulating the activity of regulatory T cells (Tregs) [24,25]. Here, CD4 is linked to neoplasm.